BioNano Robotics
Tokyo, Japan· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $200M
Overview
Develops programmable nanorobots for ultra-precise targeted drug delivery and diagnostics.
OncologyCardiovascular Diseases
Technology Platform
A platform for designing and controlling biocompatible nanorobots that can be remotely guided to specific sites in the body for targeted drug delivery or surgical procedures.
Funding History
1Total raised:$200M
Series D$200M
Opportunities
Potential to create a paradigm shift in targeted therapy, opening new treatment modalities for previously inaccessible diseases.
Risk Factors
Extreme technical, manufacturing, and regulatory challenges associated with first-in-class nanorobotic devices in humans.
Competitive Landscape
Operates in a nascent field with few pure-play competitors, but faces indirect competition from advanced drug delivery systems like lipid nanoparticles and antibody-drug conjugates.